Search

Your search keyword '"Strand C"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Strand C" Remove constraint Author: "Strand C" Search Limiters Full Text Remove constraint Search Limiters: Full Text
90 results on '"Strand C"'

Search Results

2. Understanding the current backlash against LGBTIQ+ rights through the lens of heteroactivism: A case study of the International Organization for the Family’s transnational norm diffusion on Twitter

6. Multiphysics Analysis of CFRP Charpy Tests by varying Temperatures.

7. Minimal disease activity for rheumatoid arthritis: A preliminary definition

8. Photographs of MIT environments

9. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.

10. Measures of response in clinical trials of systemic sclerosis: the combined response index for systemic sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)

11. Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer.

16. Neural substrates of cognitive load changes during a motor task in subjects with stroke.

17. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

21. Are the mitotic factors Mitotic Activity Index (MAI) and Phosphohistone 3 (PPH3) stronger prognostic proliferation factors than Ki67 in node-negative breast cancer?

23. The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling -- A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer.

36. A next-generation, histological atlas of the human brain and its application to automated brain MRI segmentation.

38. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.

39. Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma.

40. Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson's Disease and Multiple System Atrophy.

41. Optimization of AsCas12a for combinatorial genetic screens in human cells.

42. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.

43. Genetic screens in isogenic mammalian cell lines without single cell cloning.

44. Natural variation in C. elegans arsenic toxicity is explained by differences in branched chain amino acid metabolism.

45. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities.

46. Uncoupling of sgRNAs from their associated barcodes during PCR amplification of combinatorial CRISPR screens.

47. Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens.

48. Natural variation in a single amino acid substitution underlies physiological responses to topoisomerase II poisons.

49. 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.

50. The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.

Catalog

Books, media, physical & digital resources